en
en

NEWS

合一生技股份有限公司 / 2021 / A Chinese patent titled ”Use of Plectranthus amboinicus extract in manufacturing compositions for anA Taiwan patent titled “Biomarkers for lung cancer stem cells” has been granted

A Chinese patent titled ”Use of Plectranthus amboinicus extract in manufacturing compositions for anA Taiwan patent titled “Biomarkers for lung cancer stem cells” has been granted

2021-05-14

Published Date:2021-05-14

Original Link:https://www.onenessbio.com/en/news_detail42_3.htm

No 1 Date of announcement 2021/05/14 Time of announcement 18:52:44
Subject A Taiwan patent titled “Biomarkers for lung cancer stem cells” has been granted
    
To which item it meets		 paragraph 53 Date of events 2021/05/14
Statement
1.Date of occurrence of the event:2021/05/14
2.Company name:ONENESS BIOTECH CO., LTD.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office
4.Reciprocal shareholding ratios:NA
5.Cause of occurrence:The Company has been informed by the patent agency that
a Taiwan patent titled ”Biomarkers for lung cancer stem cells” has been granted under patent number I727132.
6.Countermeasures:None
7.Any other matters that need to be specified:
(1)This patent is for biomarkers for lung cancer stem cells which could be applied to cancer diagnosis and target patient screening. In addition, the expression of such biomarkers had been demonstrated to correlate with the prognosis of the patients, which predict the survival and recurrence in patents with the lung cancer.
(2)The patent is owned by National Taiwan University. Oneness has been exclusively authorized to use this patent and to manufacture, use and sell the products of this invention.